Medications

Tirzepatide improves kidney outcomes in T2DM with increased CV risk

An exploratory analysis of data from the SURPASS-4 trial has shown that adults with type 2 diabetes and increased cardiovascular risk receiving tirzepatide experience fewer renal complications, especially new onset of macroalbuminuria; ...

Cardiology

Iliac vein stenting appears safe in office-based lab setting

(HealthDay)—Iliac vein stenting seems safe in an office-based laboratory (OBL) setting, with few major complications and minor complications primarily including insertion site hematomas, according to a study published in ...

Cardiology

Risk factors ID'd for atrial fibrillation with type 1 diabetes

(HealthDay)—Older age, cardiovascular comorbidities, and renal complications increase the risk for atrial fibrillation (AF) in patients with type 1 diabetes, according to a study published online June 6 in Diabetes Care.

page 1 from 3